UPDATE : Monday, September 7, 2020
상단여백
Medytox, Daewoong still in dispute over Nabota's spore appraisal by Lee Han-soo 2019-10-15 11:28
Kolon Life Science shares surge after TissueGene’s survival by Jeong Sae-im 2019-10-14 18:01
Lilly’s Taltz shows superiority to Tremfya in treating psoriasis patients by Lee Han-soo 2019-10-14 18:01
First lung disease reported here with suspected ties to vaping by Lee Han-soo 2019-10-14 18:01
HLB merges with Elevar to own rivoceranib rights by Jeong Sae-im 2019-10-14 14:43
라인
HanAll's Chinese partner ends P2 trial of dry eye treatment by Lee Han-soo 2019-10-14 14:08
[Special] How are Korean employees coping with big-pharma M&As? by Kim Yun-mi 2019-10-14 13:45
Sanofi releases data showing improved survival for prostate cancer treatment by Lee Han-soo 2019-10-14 12:16
Regulator keeps Kolon Tissuegene listed with 1-year grace period by Lee Han-soo 2019-10-12 09:41
GC to market Merck's diabetes treatment by Lee Han-soo 2019-10-11 18:13
라인
Bayer drugs out of stock in Korea by Lee Han-soo 2019-10-11 16:36
Drug regulator to hire 87 more reviewers next year by Lee Hye-seon 2019-10-11 16:35
Sanofi to cover part of Dupixent cost for atopic dermatitis patients by Kim Yun-mi 2019-10-11 15:13
‘Direct-to-consumer genetic testing needs preparation’ by Kim Eun-young 2019-10-11 15:12
Takeda Korea’s labor union goes on strike by Lee Han-soo 2019-10-11 14:33
라인
Roche’s Tecentriq combo therapy shows encouraging results by Lee Han-soo 2019-10-10 17:36
Yuyu confirms safety of its antiplatelet drug by Lee Han-soo 2019-10-10 17:35
ICDM 2019 to host 3-day meet in Seoul by Lee Han-soo 2019-10-10 16:02
Doctors call Boehringer Ingelheim’s Jardiance marketing ‘unethical’ by Kim Yun-mi 2019-10-10 16:01
Researchers use lung cancer organoid to select best drug for patients by Lee Han-soo 2019-10-10 16:00
여백
여백
여백
Back to Top